BioMarin Pharmaceutical
BMRN
#1741
Rank
โ‚ฌ10.86 B
Marketcap
56,08ย โ‚ฌ
Share price
0.26%
Change (1 day)
19.93%
Change (1 year)

EPS for BioMarin Pharmaceutical (BMRN)

EPS in 2026 (TTM): -0,08377ย โ‚ฌ

According to BioMarin Pharmaceutical's latest financial reports the company's current EPS (TTM) is -0,08195ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of 1,66ย โ‚ฌ a decrease over its 2024 EPS that were of 2,05ย โ‚ฌ.

EPS history for BioMarin Pharmaceutical from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-0,08377ย โ‚ฌ-105.05%
20251,66ย โ‚ฌ-19.11%
20242,05ย โ‚ฌ152.81%
20230,81ย โ‚ฌ15.79%
20220,70ย โ‚ฌ-319.62%
2021-0,32ย โ‚ฌ-107.38%
20204,32ย โ‚ฌ-3485.71%
2019-0,13ย โ‚ฌ-67.44%
2018-0,39ย โ‚ฌ-34.85%
2017-0,60ย โ‚ฌ-83.21%
2016-3,58ย โ‚ฌ263.89%
2015-0,98ย โ‚ฌ18.68%
2014-0,83ย โ‚ฌ
2012-0,87ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
1,80ย โ‚ฌ-2,300.59%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-4,73ย โ‚ฌ 5,666.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-0,35ย โ‚ฌ 322.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-0,01821ย โ‚ฌ-77.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
-0,10ย โ‚ฌ 22.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
1,65ย โ‚ฌ-2,111.11%๐Ÿ‡บ๐Ÿ‡ธ USA